Advanced Search

    Technical Analysis for DICE - DICE Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 26.05 -1.92% -0.51
    DICE closed down 1.92 percent on Wednesday, March 22, 2023, on 1.27 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical DICE trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Earnings Movers Other -1.92%
    Inside Day Range Contraction -1.92%
    Earnings Movers Other -0.95%
    Fell Below 20 DMA Bearish -9.61%
    Inside Day Range Contraction -9.61%
    Crossed Above 20 DMA Bullish -11.72%
    Outside Day Range Expansion -11.72%
    Older End-of-Day Signals for DICE ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    60 Minute Opening Range Breakdown about 10 hours ago
    Up 3% about 10 hours ago
    Possible NR7 about 11 hours ago
    Up 2% about 11 hours ago
    60 Minute Opening Range Breakout about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    DICE Therapeutics, Inc. Description

    DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It designs and develops therapies in immunology for patients with chronic diseases. The company's lead therapeutic candidate, S011806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin and aVß1/aVß6 integrin for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis. The company was founded in 2013 and is headquartered in South San Francisco, California.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Pharmacy Inflammation Inflammatory Bowel Disease Chronic Disease Idiopathic Pulmonary Fibrosis Treatment Of Inflammatory Bowel Disease Interleukin 17

    Is DICE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 22 Here’s Why Meridian Small Cap Growth Fund Trimmed DICE Therapeutics (DICE)
    Mar 15 DICE Therapeutics GAAP EPS of -$0.51 misses by $0.03
    Mar 15 DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
    Mar 1 DICE Therapeutics Announces Late-Breaking Presentation at the 2023 American Academy of Dermatology (AAD) Annual Meeting
    Feb 8 DICE Therapeutics to Participate at Upcoming Investor Conferences
    Jan 25 DICE Therapeutics: Risks To Reversal Rally Noted In Market Data (Technical Analysis)
    Jan 24 DICE Therapeutics: Oral Drug Of Proven IL-17 Target
    Jan 4 DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
    Jan 2 Are Medical Stocks Lagging DICE Therapeutics (DICE) This Year?
    Dec 16 Is DICE Therapeutics (DICE) Stock Outpacing Its Medical Peers This Year?
    See more DICE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 45.99
    52 Week Low 12.635
    Average Volume 464,249
    200-Day Moving Average 25.62
    50-Day Moving Average 29.66
    20-Day Moving Average 28.80
    10-Day Moving Average 27.37
    Average True Range 1.98
    RSI 39.39
    ADX 19.08
    +DI 12.56
    -DI 21.90
    Chandelier Exit (Long, 3 ATRs) 27.12
    Chandelier Exit (Short, 3 ATRs) 31.64
    Upper Bollinger Bands 32.39
    Lower Bollinger Band 25.20
    Percent B (%b) 0.12
    BandWidth 24.97
    MACD Line -0.88
    MACD Signal Line -0.65
    MACD Histogram -0.2343
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 28.16
    Resistance 3 (R3) 28.36 27.86 27.81
    Resistance 2 (R2) 27.86 27.32 27.76 27.69
    Resistance 1 (R1) 26.96 26.99 26.71 26.75 27.57
    Pivot Point 26.46 26.46 26.33 26.35 26.46
    Support 1 (S1) 25.55 25.92 25.30 25.35 24.53
    Support 2 (S2) 25.05 25.59 24.95 24.41
    Support 3 (S3) 24.15 25.05 24.29
    Support 4 (S4) 23.94